Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer

@inproceedings{Groheux2012PrognosticIO,
  title={Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer},
  author={David Groheux and Elif Hindi{\'e} and Marc Delord and Sylvie Giacchetti and Anne-Sophie Hamy and Cedric de Bazelaire and Anne de Roquancourt and Laetitia Vercellino and M E Toubert and Pascal Merlet and Marc Espie},
  booktitle={Journal of the National Cancer Institute},
  year={2012}
}
BACKGROUND This study prospectively evaluated the yield of fluorodeoxyglucose positron emission tomography/computed tomography ((18)FDG-PET-CT) in patients with clinical stages II and III breast cancer and the impact of PET-CT results on prognosis. METHODS In the course of 71 months, 254 consecutive patients with clinical stages II and III breast cancer (based on clinical examination, mammography, breast magnetic resonance imaging, and locoregional ultrasonography) underwent (18)FDG-PET-CT… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS